DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
> This Story

starstarstarstarstar (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

MRI Homepage

Bruker and the Champalimaud Foundation to develop first 18 Tesla UHF MR scanner Enable discovery of new contrast mechanisms

Helium shortage could have deflating effect on MR industry Party City cites shortage as contributor to 45 stores closing

Whole body MR may support faster, less expensive cancer treatment planning A single scan for planning and staging, but challenges remain

MR method could spare patients with skull lesions from CT, says study Could benefit children and pregnant women

Synaptive unveils dedicated head MR system, Evry Will help in assessing the role of MR in emergency departments

AI comparable to radiologists in prostate cancer detection accuracy Identifies and predicts aggressiveness using MR scans

New study shows value of 7T MR for evaluating MS progression Can detect cortical lesions better than conventional scanners

Trice Imaging connects imaging devices of large chain healthcare provider Aleris Patients and physicians can view images on laptops, cell phones

The benefits of intraoperative MR Q&A with Dr. John Huston Mayo Clinic neuroradiologist discusses what the advanced capabilities mean for patients – as well as providers

Sound Imaging launches MR patient motion and detection system, SAMM MD Reduces repeat scans, prevents interruption to workflow

New MR methodology may distinguish benign and cancerous lymph nodes

by John R. Fischer , Staff Reporter
Researchers at the Champalimaud Centre for the Unknown in Portugal have introduced a new MR methodology for determining whether a tumor has metastasized into the lymph nodes of the mesorectum in rectal cancer patients.

The approach can be performed prior to the surgical removal of the tumor, rectum and mesorectum, which is the standard for determining if the cancer has spread to the lymph nodes and plays a role in determining what the right form of treatment should be. If validated, the researchers claim the method could be used to help determine the optimal course of action for addressing the cancer beforehand.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



"The pathologic status of lymph nodes in the mesorectum constitutes one of the most important prognostic markers in rectal cancer patients", Inês Santiago, the lead author of this study, said in a statement. "However, with currently implemented imaging protocols, knowledge of lymph node status before surgery is limited, so decision-making is largely based on other tumour characteristics."

Previous studies have claimed the use of radiotherapy and/or chemotherapy could be effective courses of treatment for high-risk patients if administered before surgery. Determining how to approach a patient’s treatment requires findings from the same surgery, placing clinicians in a "Catch 22" scenario which can lead to overtreatment. The risk has caused many radiologists to be very conservative in their assessment of lymph node status, as well as the fact that radiation and chemotherapy may have adverse and sometimes irreversible side effects.

The methodology utilizes Susceptibility Perturbation Magnetic Resonance Imaging (SPI) to differentiate between benign and cancerous lymph nodes. Applying the technique on a ultra-high magnetic field preclinical MR scanner, the team observed a difference between benign and malignant lymph nodes, and confirmed the findings using conservative pathological analyses.

They then adapted the technique for a conventional scanner with a lower magnetic field, and assessed patients using both SPI and the current "gold standard" MR method. Post-surgical analysis of the lymph nodes found that SPI increased the accuracy of lymph node characterization, compared to the standard MR approach, providing greater sensitivity and no loss in specificity.

"We know that normal lymph nodes are composed of a relatively uniform distribution of small, loosely-packed cells. By contrast, cancer-involved lymph nodes are characterised by the presence of large, tightly-packed malignant cells", said author Noam Shemesh. "We knew that this difference in size should induce a kind of "distortion" in local magnetic fields, so we hypothesised that this effect could be exploited to noninvasively differentiate between normal and affected nodes using MRI. To do this, we had to develop a novel MRI methodology, which we named Susceptibility Perturbation Magnetic Resonance Imaging (SPI), as well as a new analysis framework to better understand the sources of its signals."

The team has extended the study to other centers to optimize the use of SPI in clinical settings and cross-validate findings.

The findings were published in the journal, Cancer Research.

MRI Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED